GlaxoSmithKline's 'Unexpected Disappointment'

By: via Benzinga
GlaxoSmithKline plc (ADR) (NYSE: GSK) is near its 52-week lows after having fallen 6.2 percent this year. Following topline results ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.